Join the Deucravacitinib group to help and get support from people like you.
Deucravacitinib Support Group
Summary
Our support group for Deucravacitinib has 3 questions and 3 members. Updated 28 Feb 2023.
Latest questions
Further information
Related condition support groups
Deucravacitinib Patient information at Drugs.com
Latest news
FDA Approves Sotyktu (deucravacitinib) for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis
Bristol Myers Squibb’s Sotyktu, a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor,…
Ask a question
To post your own question to this support group, sign in or create an account.